| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9264 |
Injection, paclitaxel protein-bound particles, 1 mg |
6,494 |
1,822 |
$17.38M |
| J9299 |
Injection, nivolumab, 1 mg |
1,610 |
880 |
$8.13M |
| J9395 |
Injection, fulvestrant, 25 mg |
1,963 |
1,837 |
$2.34M |
| J9271 |
Injection, pembrolizumab, 1 mg |
262 |
193 |
$1.82M |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
1,029 |
225 |
$1.64M |
| J2997 |
Injection, alteplase recombinant, 1 mg |
20,138 |
7,826 |
$1.43M |
| 99215 |
Prolong outpt/office vis |
25,766 |
13,398 |
$1.36M |
| J1453 |
Injection, fosaprepitant, 1 mg |
2,113 |
1,035 |
$824K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14,949 |
4,704 |
$801K |
| 36593 |
|
20,063 |
7,860 |
$523K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,346 |
4,501 |
$471K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,229 |
3,719 |
$468K |
| J9070 |
Cyclophosphamide, 100 mg |
3,360 |
1,149 |
$465K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
16,599 |
5,127 |
$391K |
| J0897 |
Injection, denosumab, 1 mg |
201 |
186 |
$383K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,669 |
5,039 |
$356K |
| 96367 |
|
8,185 |
3,038 |
$238K |
| J7050 |
Infusion, normal saline solution, 250 cc |
18,240 |
5,682 |
$144K |
| 96417 |
|
5,491 |
2,383 |
$138K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,065 |
4,497 |
$136K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,590 |
4,295 |
$100K |
| 96415 |
|
3,809 |
2,192 |
$93K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,065 |
1,479 |
$68K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,098 |
439 |
$47K |
| J3489 |
Injection, zoledronic acid, 1 mg |
847 |
786 |
$47K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
8,003 |
3,487 |
$32K |
| 99195 |
|
2,094 |
988 |
$26K |
| 96402 |
|
2,294 |
2,141 |
$21K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
3,667 |
2,810 |
$18K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
147 |
66 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
646 |
483 |
$14K |
| J9045 |
Injection, carboplatin, 50 mg |
293 |
111 |
$10K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,467 |
574 |
$7K |
| 96409 |
|
524 |
229 |
$6K |
| J9190 |
Injection, fluorouracil, 500 mg |
119 |
54 |
$4K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
61 |
51 |
$3K |
| 99233 |
Prolong inpt eval add15 m |
45 |
12 |
$2K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
338 |
155 |
$1K |
| 96416 |
|
24 |
12 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
121 |
51 |
$1K |